碳酸酶抑制剂:结构见解和治疗潜力
Priti Singh1, Mohammed Arifuddin2, Claudiu T Supuran3
1Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad 500 037, India.
Bioorganic chemistry
|February 2, 2025
概括
这篇评论探讨了新型碳酸酶抑制剂 (CAI) 用于治疗眼和癌症等疾病. 不同的化学类别显示了针对碳酸酶 (CA) 异形抑制和新药开发的前景.
科学领域:
- 药用化学 医学化学
- 生物化学 生化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 碳酸胺酶抑制剂 (CAI) 对于管理诸如眼光瘤,和癌症等疾病至关重要.
- 碳酸 anhydrase (CA) 异型在各种生理和病理过程中发挥着至关重要的作用.
- 准特定的CA异型为许多疾病提供治疗潜力.
研究的目的:
- 审查新型碳酸酶抑制剂 (CAI) 的设计和开发方面的最新进展.
- 突出CAI的各种化学类别及其独特的结构特征.
- 探索这些抑制剂的治疗应用和潜力.
主要方法:
- 关于碳酸酶抑制剂的最近研究的文献综述.
- 分析各种化学类别,包括醇,硫氨酸,三醇,尿素衍生物,石墨烯,烯和氨酸.
- 检查CA异形抑制的结构-活性关系和机制.
主要成果:
- 确定了几种具有独特抑制特征的CAI的有前途的化学类.
- 证明了对特定的碳酸无水酶异型的选择性抑制潜力.
- 突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出
结论:
- 最近CAI开发的进展为CAI相关疾病提供了新的治疗策略.
- 对各种化学支架的探索继续扩大碳酸酶抑制的景观.
- 这些进展为针对未满足的医疗需求的新药发现铺平了道路.
相关概念视频
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
462
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
462
Antihypertensive Drugs: Thiazide-Class Diuretics
525
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
525
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
375
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
375
Antihypertensive Drugs: Direct Renin Inhibitors
477
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
477
Aldehydes and Ketones with HCN: Cyanohydrin Formation Overview
2.6K
Cyanohydrins are compounds that contain –CN and –OH groups on the same carbon atom. They are formed by the nucleophilic addition of the cyanide ions to the carbonyl group. Cyanide ions are highly basic and nucleophilic and can be generated from HCN under aqueous conditions. However, since HCN is a weak acid, the number of cyanide ions generated is very small. Hence, a small amount of base or KCN/NaCN is added to HCN to increase the concentration of the cyanide ions in the reaction...
2.6K
Antihypertensive Drugs: Potassium-Sparing Diuretics
441
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
441


